| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $85,348,698 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | RF1AG027297 | Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease | 000 | 11 | NIH | 1/27/2022 | $249,287 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R37CA227656 | The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia | 000 | 5 | NIH | 4/15/2022 | $349,988 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS103785 | Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury | 001 | 4 | NIH | 3/28/2022 | $32,722 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS103785 | Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury | 000 | 4 | NIH | 12/14/2021 | $294,482 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01GM129532 | Visceral fat gamma delta T cells in sepsis pathogenesis | 000 | 5 | NIH | 6/6/2022 | $320,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01EB026893 | Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors | 000 | 5 | NIH | 6/3/2022 | $494,605 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DC017025 | ATP-purinergic mechanisms underlying noise-induced cochlear synaptopathy and hearing loss | 001 | 5 | NIH | 4/21/2022 | $32,513 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DC017025 | ATP-purinergic mechanisms underlying noise-induced cochlear synaptopathy and hearing loss | 000 | 5 | NIH | 2/11/2022 | $292,612 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA045023 | A translational determination of the mechanisms of maladaptive choice in cocaine use disorder | 000 | 5 | NIH | 4/15/2022 | $604,599 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA214638 | A redox-mediated mechanism of UVB-induced metabolic switch in skin carcinogenesis | 001 | 5 | NIH | 5/17/2022 | $32,914 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA214638 | A redox-mediated mechanism of UVB-induced metabolic switch in skin carcinogenesis | 000 | 5 | NIH | 12/2/2021 | $370,291 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS102196 | RIT1-mediated Protection following Traumatic Brain Injury | 001 | 5 | NIH | 3/28/2022 | $50,901 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS102196 | RIT1-mediated Protection following Traumatic Brain Injury | 000 | 5 | NIH | 1/26/2022 | $458,098 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01DK116923 | Social Network Analysis and Social Support Intervention for Rural Dwelling Older Adults with T2DM | 000 | 4 | NIH | 12/15/2021 | $121,083 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA222596 | Role of Sulfiredoxin in Colorectal Cancer Development | 001 | 5 | NIH | 5/23/2022 | $27,994 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA222596 | Role of Sulfiredoxin in Colorectal Cancer Development | 000 | 5 | NIH | 1/18/2022 | $314,920 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01EY027805 | Comprehensive analysis of periocular mesenchyme composition, specification and function during anterior segment formation | 000 | 5 | NIH | 2/3/2022 | $368,128 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U18FD006179 | FDA Vet-LIRN Veterinary Diagnostic Laboratory Cooperative Agreement Program funding to increase sample analysis in the event of animal food or drug related illness | 000 | 6 | FDA | 5/31/2022 | $40,200 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA044311 | Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal Phenotypes | 002 | 6 | NIH | 3/31/2022 | $33,317 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA044311 | Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal Phenotypes | 001 | 6 | NIH | 2/1/2022 | $100,396 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA044311 | Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal Phenotypes | 000 | 6 | NIH | 1/31/2022 | $299,844 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA044311 | Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal Phenotypes | 003 | 6 | NIH | 3/31/2022 | $11,155 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA043938 | Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use | 000 | 5 | NIH | 5/18/2022 | $574,367 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25ES027684 | Summer Research in Environmental Health Sciences | 000 | 5 | NIH | 5/4/2022 | $98,051 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR073906 | Epigenetic control of muscle stem cell function by PASK-Wdr5 signaling | 001 | 4 | NIH | 5/27/2022 | $30,290 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR073906 | Epigenetic control of muscle stem cell function by PASK-Wdr5 signaling | 000 | 4 | NIH | 11/19/2021 | $302,881 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA218068 | Randomized Trial of a Social Media-Delivered Intervention Targeting Indoor Tanning Users | 000 | 6 | NIH | 6/9/2022 | $365,287 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F30NS118777 | Investigating Angiogenic Mediators as Biomarkers and Targets for Rescuing Small Vessel Disease in a Model of VCID | 001 | 2 | NIH | 6/9/2022 | -$1 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F30NS118777 | Investigating Angiogenic Mediators as Biomarkers and Targets for Rescuing Small Vessel Disease in a Model of VCID | 000 | 2 | NIH | 5/6/2022 | $35,712 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P20GM121327 | University of Kentucky Center for Cancer Metabolism | 001 | 6 | NIH | 2/15/2022 | $2,289,653 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL135158 | Effect of early life stress on obesity-induced hypertension in mice | 002 | 5 | NIH | 6/9/2022 | $38,250 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL135158 | Effect of early life stress on obesity-induced hypertension in mice | 001 | 5 | NIH | 12/15/2021 | $32,535 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL135158 | Effect of early life stress on obesity-induced hypertension in mice | 000 | 5 | NIH | 11/20/2021 | $344,250 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG019223 | Ceramide and acute phase proteins elevation during aging | 001 | 16 | NIH | 6/8/2022 | $79,245 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK048498 | Mechanistic Impact of PI3K/mTOR Signaling on Intestinal Homeostasis | 004 | 27 | NIH | 6/10/2022 | $375,915 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG038651 | Role of impaired cognitive states & risk factors in conversion to mixed dementias | 000 | 9 | NIH | 2/16/2022 | $530,404 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG038651 | Role of impaired cognitive states & risk factors in conversion to mixed dementias | 001 | 9 | NIH | 6/2/2022 | $58,935 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P42ES007380 | Nutrition and Superfund Chemical Toxicity | 002 | 24 | NIH | 3/23/2022 | $962,647 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P42ES007380 | Nutrition and Superfund Chemical Toxicity | 002 | 24 | NIH | 3/23/2022 | $412,563 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG026307 | Self-Regulation and Brain and Cognitive Health in Older Adults | 000 | 15 | NIH | 5/13/2022 | $637,768 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01GM070559 | Epigenetic regulation of hormone action in Tribolium and Aedes | 002 | 15 | NIH | 3/30/2022 | $268,830 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01HS025494 | Examining the Integration of Hospitals, Public Health, and Social Services to Target the Social Determinants of Health Using Patient-Centered and Comparative Effectiveness Research Methods | 000 | 5 | AHRQ | 4/13/2022 | $137,355 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA133429 | The Role of PHLPP in Colon Cancer | 000 | 15 | NIH | 4/18/2022 | $389,590 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG037868 | Chronic Stress, Glucocorticoids, and Progesterone in Brain Aging | 000 | 7 | NIH | 6/16/2022 | $394,406 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK095662 | The Role of Crypt Fissioning in IBD Ulcer Healing | 000 | 11 | NIH | 4/14/2022 | $662,758 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA175105 | Targeting Translation Dependence in Colorectal Cancer Progression | 000 | 8 | NIH | 12/1/2021 | $327,037 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA175105 | Targeting Translation Dependence in Colorectal Cancer Progression | 001 | 8 | NIH | 5/25/2022 | $29,071 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 001 | 11 | NIH | 6/17/2022 | $498,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 001 | 11 | NIH | 6/17/2022 | $150,000 |
|
